ClinVar Miner

Submissions for variant NM_000419.5(ITGA2B):c.2975del (p.Glu992fs)

dbSNP: rs1467071163
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen RCV001225275 SCV001397542 likely pathogenic Glanzmann thrombasthenia 2023-10-17 reviewed by expert panel curation The NM_000419.5(ITGA2B):c.2975del (p.Glu992GlyfsTer?) variant has been described in at least one patient with a phenotypes highly specific to GT including mucocutaneous bleeding, impaired aggregation with all agonists except ristocetin (PMID: 22190468; PP4_moderate). This patient is compound heterozygous with Gln778Pro (classified as Pathogenic by the ClinGen Platelet Disorders VCEP) in trans (PM3). This frameshift variant occurs in exon 28 and results in 51 altered amino acids followed by as stop loss and the elongation of the protein by 90 amino acids, which alters the entirety of the transmembrane domain which is critical to protein function (PMID: 25617834) as well as the cytoplasmic domain (PVS1_Strong). The variant is reported in 1/18394 alleles (frequency of 0.00005437) in the East Asian population in gnomAD, which meets the threshold <0.0001 alleles (PM2_supporting). In summary, this variant meets criteria to be classified as likely pathogenic for GT. GT-specific criteria applied: PM2_supporting, PVS1_strong, PM3, PP4_moderate. (PD-VCEP specifications v2.1)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.